Advance Search

Helicobacter Pylori infection among Dyspeptic Patients Referred for Endoscopy

Mohammad A. Sheikhani
Department of Medicine, College of Medicine, University of Sulaimani, Sulaimania, Iraq.
Taha A. Alkarbuly
Department of Medicine, College of Medicine, University of Sulaimani, Sulaimania, Iraq.
Pshko Tahir Muhammad
Department of Medicine, College of Medicine, University of Sulaimani, Sulaimania, Iraq.
Keywords:
Copyright and Licensing:
Copyright Notice
Share:
  • Articles
  • Submited: October 29, 2018
  • Published: October 29, 2018

Abstract

Background: Dyspepsia is a relatively common clinical condition encountered by primary care physicians, lately H.pylori has been related to duodenal and gastric ulcers, and to a lesser extent, gastric malignancy. Screening for H.pylori can now be done by noninvasive techniques.

Aims: Evaluating frequency of H.pylori infection in dyspeptic patients in relation to age, gender, patient symptoms and endoscopic findings.

Patients and Methods: This prospective and descriptive study was conducted in Kurdistan Center for Gastrology and Hepatology (KCGH) on 86 dyspeptic patients, all the patients underwent Oesophageogastroduodenoscopy to find the cause of dyspepsia, a blood sample collected for determination of serum IgG for H.pylori.

Results: H.pylori account for 54(62.7%) of 86 dyspeptic patient. The incidence of the infection was higher in female patients (p=0.03), there was statistically significant difference between female and male (p=0.02). H.pylori infection is common in age groups 21-40 and 41-60 (26.7% and 23.2%) respectively, there was no relation between patient symptoms and H.pylori infection (p>0.05) except vomiting, loss of appetite and weight loss (p<0.05) also there was no association between endoscopic findings and H.pylori infection (p>0.05) except for gastric and duodenal erosion (p<0.0001).

Conclusion: H.pylori infection is frequent among dyspeptic patients, the infection is more common between ages 21-60 years and H.pylori infection has no relation to symptoms and endoscopic findings.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. TNJ, Zinsmeister AR, Schleck CD, et al.Dyspepsia&dyspepsia subgroups: Gastroenterology 1992; 102,4 Pt 1:1259–1268.
  2. K Musana, SH. Yale, and KA. Lang. Managing Dyspepsia. Clin Med Res.2006; 4,4: 337–342.
  3. TNJ&Vakil N. Practice Parameters Committee of the ACG Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100:2324–2337.
  4. Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for management.Gastroenterol Int 1991; 4:145-160.
  5. Holtmann G and Talley NJ. Functional dyspepsia. Drugs 1993; 45:918-930
  6. Armstrong D. H pylori&dyspepsia. Scand J Gastroenterol 1996; 31, 215:S38-S47.
  7. Morain C&Buckley M. H.pylori&dyspepsia. Scand J Gastroenterol 1996; 31, 214:S28-S30.
  8. Richter JE. Dyspepsia: organic causes& differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991; 182:S11-S16.
  9. Al-Moagel MA, Evans DG, Abdulg hani ME, et al. Prevalence of Helicobacter in Saudia Arabia,
  10. &comparison of those with and without UGI symptoms. Am J Gastroenterology 1990; 85:944-948.
  11. Abdul-Wahab AM and Bin-Dayna KM. Helicobacter pylori: association with UGI disease in Bahrain. Bahrain Med Bull 1994; 16:78-81.
  12. Britt DP, Barakat MH, Tungekar MF, et al. H pylori in Kuwait. J Clin Pathol 1990; 43:987-991.
  13. Talley NJ et al. Dyspepsia: A population-based study. Gastroenterology 1992; 102:1259-1262.
  14. Talley NJ, Colin-J D, Koch KL, et al. Functional dyspepsia:Gastroenterol Int 1992; 4:145-147.
  15. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. GE 2006; 130:1466-7.
  16. Kurata JH, Nogawa AN&Everhart, JE. dyspepsia in primary care. Dig Dis Sci 2002; 47:797-799.
  17. Management of dyspepsia: report of a working party. Lancet 1988; 1:576-577.
  18. Koch, KL&Stern, RM. Functional disorders of the stomach. Semin Gastrointest Dis 1996; 7:185-8.
  19. Malagelada JR. Functional dyspepsia. Insights on mechanisms and management strategies. Gastroenterol Clin North Am 1996; 25:103-104.
  20. Aroori S. Helicobacter pylori. Gastroenterol Today 2001; 5: 131-133.
  21. Klauser AG, Schindlbeck NE&Muller-Lissner SA. Symptoms in DERD. Lancet 1990; 335:205-8.
  22. Moayyedi, P&Axon, AT. Usefulness of the LR in the diagnosis of dyspepsia &GERD. Am J Gastroenterol 1999; 94:3122-3125.
  23. Gillen D and McColl KE. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 1999; 94:2329-2331.
  24. Talley, NJ. Editorial: Gallstones and upper abdominal discomfort. Innocent bystander or a cause of dyspepsia? J Clin Gastroenterol 1995; 20:182-185.
  25. Thompson WG, Longstreth G, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 Suppl 2:1143-1145.
  26. Spiegel BM, Farid M, Dulai GS, et al. Comparing rates of dyspepsia with Coxibs vs. NSAID+PPI: a meta-analysis. Am J Med 2006; 119:448-452.
  27. Karamanolis G, Caenepeel P, Arts J, et al. Association of the predominant symptom with clinical characteristics&pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130:296-299.
  28. Moayyedi P, Talley NG, Fennerty MB, et al.Can the clinical history distinguish between organic and functional dyspepsia?JAMA 2006; 295:1566-1569.
  29. Logan, Robert P H; Walker, et al.Epidemiology&diagnosis of H pylori. BMJ 2001; 323: 920–922.
  30. Marshall BJ. "Unidentified curved bacillus on gastric epithelium in active chronic gastritis". Lancet 1 (1983); 8336: 1273–1275.
  31. Marshall BJ and Warren JR. "Unidentified curved bacilli in the stomach patients with gastritis and peptic ulceration". Lancet 1 (1984); 8390: 1311–1315.
  32. Hidekazu S,Tatsuhiro M,Sachiko N,et al.Current consensus on the diagnosis and treatment of H.pylori associated gastroduodenal disease.Keio J Med 2003;52,3:163-173.
  33. L Morris &Brown.H pylori: Epid&routes of transmission. Epidemiologic Rev 2000; 22, 2:283-7
  34. Eduardo L., Pelayo C., Regina M., et al.Role and limitations of epidemiology in establishing a causal association. Seminars in Cancer Biology 2004; 14, 6:413-426.
  35. Periklis Apostolopous,Irene Vafiadis-Zouboulis,Michael Tzivras, et al.Helicobacter pylori infection in Greece:The changing prevalence,BMC Gastroenterology .2002 ;2:11;12-18.
  36. Karen J.Goodmanl and Myles Cockburn.The role of epidemiology in understanding the health effects of Helicobacter pylori .Epidemiology. 2001; 12, 2:266-271.
  37. German R, Guadalupe A. and Geny F.Helicobacter pylori: Recent advances in the study of its pathogenicity and prevention.Publica Mex. 2001; 43, 3:237-247.
  38. K.Seth, S.Kakkar and S.manchanda.Role of biopsy from gastric corpus in diagnosis of Helicobacter pylori infection in patients on acid suppression therapy.MJAFI.2003;5,3:216-217.
  39. Richard Saad and William d. Chey.A clinicians guide to managing Helicobacter pylori infection.Cleveland Clinic Journal of Medicine. 2005; 72, 2: 110-112.
  40. Reilly J. Appropriate prescribing for Helicobacter pylori infection. Located at: Peptic ulcer disease: Update with the experts, Medical Education Collaborative, Golden, Colorado. 2001
  41. Ho B& Marshall BJ. Accurate diagnosis.Gastroenterol Clin North Am 2000; 29, 4:853–862.
  42. Loy CT, Irwig LM, Katelaris PH, et al. Do commercial serological Kits for H pylori differ in accuracy? Ametaanalysis.AmJ Gastroenterol1996; 91:1138–1144.
  43. Chey WD, Murthy U, Shaw S, et al. A comparison of three finger stick, Whole blood antibody tests for H pylori infection: a United States, multicentertrial. Am J Gastroenterol 1999; 94:1512–1516.
  44. Chey WD and Scheiman JM. Chapter 20: Peptic Ulcer Disease. In: McQuaid K, editor. Current Diagnosis and Treatment in Gastroenterology. 2nd ed.NewYork:McGraw-Hill;2003:323–341.
  45. Graham DY&Klein PD.Diagnosis of H pylori by breath test. Gastroenterol Clin North Am 2000; 29,4:885–893.
  46. Del Valle J, Chey WD and Scheiman JM. Acid peptic disorders. In: Alpers DH, editor. Textbook of Gastroenterology. Philadelphia: Lippincott Williams andWilkins;2003:1328–1376.
  47. Chey WD. Diagnosis of H pylor. Gastroenterol Clin North Am 2000; 29, 4:895–902.
  48. Chey WD, Metz DC, Shaw S,et al. Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infection. Am J Gastroenterol 2000; 95:1171–1174.
  49. Chey WD, Murthy U, Toskes P, et al. The 13C-urea blood test accurately detects active H pylori: a United States, multicenter trial. Am J Gastroenterol 1999; 94:1522–1524.
  50. Vaira D, Menegatti M, Ricci C, et al.Accurate diagnosis of H pylori. Stool tests. Gastroenterol Clin North Am 2000; 29, 4:917–923.
  51. Odaka T, Yamaguchi T, Koyama H, et al. Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. Am J Gastroenterol 2002; 97:594–599.
  52. Vaira D, Vakil N, Menegatti M, et al. The stool antigen test for detection Of Helicobacter pylori after eradication therapy. Ann Intern Med 2002; 136:280–287.
  53. Bravo LE, Realpe JL, Campo C, et al. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol 1999; 94:2380–2383.
  54. Talley, Axon , Bytzer , et al. Management of uninvestigated a& functional dyspepsia. Aliment Pharmacol Ther 1999; 13:1135-1148.
  55. Westbrook JA, McIntosh JH, Duggan JM. Accuracy of provisional Diagnoses of dyspepsia in patients undergoing first endoscopy. Gastrointestinal Endoscopy 2001; 53:283-288.
  56. How den CW. For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection? Gastroenterology 1997; 113:S107-112.
  57. Talley RJ and Hunt R. What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H pylori being associated with dyspeptic symptoms. Gastroenterology 1997; 113:S67-77.
  58. Mc K, Murray L,et al. Symptomatic benefit to eradicate H pylori.NEJM 1998; 339:1869-1874.
  59. Lassen AT, Pedersen FM, Bytzer P, et al. H pylori test. Lancet 2000; 356:455-460.
  60. Silverstein, Petterson. Initial endoscopy or empirical therapy.Gastroenterology96; 110:72-83.
  61. Groeneveld, Lieu et al. Quality of life measurement in dyspepsia. AJGE 2001; 96:338-346.
  62. Veldhuyzen van Zanten SJO, Jones MJ, Verlinden M, et al. Efficacy of Cisapride and Dom-peridone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterology 2001; 96:689-6.
  63. Parsonnet J, Harris RA, Hack HM, et al. Modeling cost effectiveness of H pylori screening to prevent gastric cancer. Lancet 1996; 348:150-154.
  64. Fuad A.Baban&Mohammad O.Mohammad.The prevalence of H. (JZS) 2003; A 6, 1:1-8.
  65. Zana Tahseen A.A comparative study among biopsies from antrum, body&incicura angularis of stomach in diagnosis of chronic gastritis with correlation to H pylori. 2007; 4.1:72-73.
  66. Haim Shmuely,Samson Obure,Douglas J.Passaro,et al.Dyspepsia symptoms and Helicobacter pylori infection,Nakuru,Kenya.Emerging infection disease 2003;9,l 9:1103-1107.
  67. Rajesh K,B,Kapoor, et al.Clin profile in H.pylori positives in Jammu.JK science 2006;8,l 3:148-0.
  68. Rathbone BJ, Wyatt J & Heatley RV. Symptomatology in C. pylori;Gut 1988; 29:A147-149.
  69. Sobala GM, Dixon MF and Axon ATR. H. pylori is not associated with a distinct dyspeptic syndrome. Gut 1989; 30:A733-734.
  70. Strauss RM, Wang TC, Kelsey PB, et al. Association of H Pylori infection with dyspeptic symptoms.Gastroduodenoscopy. Am J Med 1990; 89:464-469.
  71. Tsega E, Gebre W, Manley P,et al. Helicobacter pylori, gastritis and non-ulcer dyspepsia in Ethiopian patients. Ethiop Med J 1996; 34:65-71.
  72. Eman A.Abahussain, Fuad A.M.Hasan and Paul J.Nicholls.Dyspepsia and Helicobacter pylori infection: Analysis of 200 Kuwaiti patients referred for endoscopy.Annals of Saudi Medicine 1998; 18, 6:502-505.
How to Cite
Sheikhani, M. A., Alkarbuly, T. A., & Muhammad, P. T. (2018). Helicobacter Pylori infection among Dyspeptic Patients Referred for Endoscopy. Zanco Journal of Medical Sciences (Zanco J Med Sci), 14(1 Special), 37–43. Retrieved from https://zjms.hmu.edu.krd/index.php/zjms/article/view/489

Send mail to Author

Send Cancel